Spermosens Balance Sheet Health

Financial Health criteria checks 1/6

Spermosens has a total shareholder equity of SEK22.0M and total debt of SEK626.0K, which brings its debt-to-equity ratio to 2.8%. Its total assets and total liabilities are SEK25.0M and SEK3.0M respectively.

Key information

2.8%

Debt to equity ratio

SEK 626.00k

Debt

Interest coverage ration/a
CashSEK 129.00k
EquitySEK 21.97m
Total liabilitiesSEK 3.03m
Total assetsSEK 25.00m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 9R5's short term assets (SEK738.0K) do not cover its short term liabilities (SEK1.1M).

Long Term Liabilities: 9R5's short term assets (SEK738.0K) do not cover its long term liabilities (SEK1.9M).


Debt to Equity History and Analysis

Debt Level: 9R5's net debt to equity ratio (2.3%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 9R5's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 9R5 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 9R5 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26% each year


Discover healthy companies